Drug Research
Eisai’s DAYVIGO gets approval in Japan to treat insomnia
Eisai Co., Ltd. announced that it has obtained the manufacturing and marketing approval in Japan for its in-house discovered orexin receptor antagonist DAYVIGO (2.5mg,...
Clinical Trials
First-of-its-Kind Bio-Artificial Pancreas on Track for Type-I Diabetes Cure
Imagine a world where those living with Type 1 Diabetes, a chronic illness affecting more than 60 million adults globally, no longer had to...
Drug Research
Eisai Commences Joint Research and Development of Cancer Gene Panel Test With Personal Genome Diagnostics Inc
Eisai Co., Ltd. announced that it has entered into a joint research and development agreement with Personal Genome Diagnostics Inc. for the cancer genetics...
Drug Research
Medigene, IRICoR and Universite de Montreal sign collaboration and exclusive licensing option on novel cancer antigens
Medigene AG , a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announces that it has entered into a research collaboration...
Press Releases
Signant Health Enhances Audit Trail Reporting Capabilities in TrialMax to Improve eCOA Data Integrity Monitoring
Signant Health has announced new audit trail reviewing and reporting functionality for its electronic clinical outcome assessment (eCOA) and remote sensor platform, TrialMax®. This...
News
Pharmapack Europe unpacks key drivers and challenges in 2020
Pharmapack Europe (#pharmapackeu), organised by Informa Markets, has pinpointed a number of opportunities and threats that drug delivery and pharmaceutical packaging companies must address...
IT & Data Management
Aptar Pharma Partners with Lupin to Launch India’s First Connected Smart Device for Respiratory Disease, ADHERO
Aptar Pharma, a global leader in drug delivery systems, services and active packaging solutions, is pleased to announce that it has partnered with Lupin...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read